The dispute between the promoters of Hikal, a manufacturer of various chemical intermediates, specialty chemicals, and active pharma ingredients, has taken a new twist. Escalating the dispute, the Kalyani Group – BF Investment Ltd (BFIL) and Kalyani Investment Company Ltd (KICL) have accused Hikal of making “entirely inaccurate and misleading” disclosure to the stock exchanges. BFIL and KICL on Saturday disclosed to the stock exchanges that they are not parties to any family arrangement with respect to equity shares held by them in Hikal and the shares held...
The dispute between the promoters of Hikal, a manufacturer of various chemical intermediates, specialty chemicals, and active pharma ingredients, has taken a new...